Jinan Acetate Chemical Co., Ltd. (4763.TW)
TWD 910.0
(0.66%)
TWD 910.0
(0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.24 Billion | 1.6 Billion | 455.14 Million | 294.72 Million | 488.46 Million | 345.97 Million |
| Net Income | 6.13 Billion | 1.41 Billion | 365.44 Million | 552.85 Million | 378.36 Million | 210.05 Million |
| Depreciation & Amortization | 277.44 Million | 179.88 Million | 134.56 Million | 105.37 Million | 98.22 Million | 89.11 Million |
| Deferred income taxes | -626.13 Million | - | - | - | - | - |
| Stock-based compensation | 91.54 Million | 10.04 Million | - | - | - | - |
| Change in working capital | 505.06 Million | 350.7 Million | -11 Million | -281.43 Million | 38.44 Million | 89.98 Million |
| Other non-cash items | -134.12 Million | -345.49 Million | -33.85 Million | -82.06 Million | -26.56 Million | -43.17 Million |
| Investing Cash Flow | -684.81 Million | -240.33 Million | -690.17 Million | -123.77 Million | -258.17 Million | -14.86 Million |
| Investments in PPE | -447.13 Million | -650.18 Million | -528.88 Million | -221.17 Million | -127.64 Million | -190.17 Million |
| Acquisitions | 142.1 Million | 346.07 Million | 39 Thousand | 1.14 Million | 1.97 Million | - |
| Investment purchases | -445.5 Million | -11.81 Million | -164.44 Million | -3.79 Million | -145.41 Million | - |
| Sales/Maturities of investments | 65.48 Million | 118.24 Million | -39 Thousand | 98.68 Million | 633 Thousand | 183.88 Million |
| Other Investing Activities | 240 Thousand | -42.66 Million | 3.15 Million | 1.36 Million | 12.27 Million | -8.56 Million |
| Financing Cash Flow | 733.26 Million | -46.92 Million | 60.89 Million | 74 Million | 7.42 Million | -167.81 Million |
| Debt repayment | -401.7 Million | -429.14 Million | -148.72 Million | -365.01 Million | -167.75 Million | -169.13 Million |
| Dividends payments | -997.47 Million | -314.1 Million | -274.96 Million | -237.64 Million | -183.86 Million | -232.4 Million |
| Common Stock Repurchased | 36.25 Million | - | -38.08 Million | -52.31 Million | -11.46 Million | -52.12 Million |
| Common Stock Issuance | 2.14 Billion | 307.6 Million | 522 Million | -365.01 Million | - | - |
| Other Financing Activities | -45.39 Million | 388.71 Million | 658 Thousand | 1.09 Billion | 202.75 Million | 116.71 Million |
| Accounts receivables | -123.03 Million | 238.29 Million | 222.38 Million | -232.39 Million | -134.57 Million | 65.44 Million |
| Accounts payables | -109.28 Million | 148.93 Million | -17.42 Million | -64.89 Million | 1.08 Million | -96.03 Million |
| Inventory | -116.02 Million | 8.12 Million | -163.31 Million | 22.72 Million | 77.06 Million | 95.36 Million |
| Other working capital | 853.4 Million | -44.64 Million | -52.65 Million | -6.86 Million | 94.86 Million | -5.38 Million |
| Cash at beginning of period | 1.94 Billion | 646.16 Million | 831.33 Million | 589.26 Million | 369.07 Million | 206.24 Million |
| Cash at end of period | 8.11 Billion | 1.94 Billion | 646.16 Million | 831.33 Million | 589.26 Million | 369.07 Million |
| Capital Expenditure | -447.13 Million | -650.18 Million | -528.88 Million | -221.17 Million | -127.64 Million | -190.17 Million |
| Effect of forex changes on cash | -122.94 Million | -26.87 Million | -11.03 Million | -2.88 Million | -17.53 Million | -462 Thousand |
| Net cash flow / Change in cash | 6.17 Billion | 1.29 Billion | -185.16 Million | 242.06 Million | 220.18 Million | 162.83 Million |
| Free Cash Flow | 5.8 Billion | 958.8 Million | -73.73 Million | 73.55 Million | 360.82 Million | 155.79 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.75 Billion | 2.1 Billion | 6.13 Billion | 2.27 Billion | 1.86 Billion | 1.35 Billion |
| Depreciation & Amortization | 61.78 Million | 126.65 Million | 277.44 Million | 56.48 Million | 114.74 Million | 58.4 Million |
| Deferred income taxes | - | - | -626.13 Million | - | -143.06 Million | -123.52 Million |
| Stock-based compensation | - | - | 91.54 Million | - | 31.98 Million | -68 Thousand |
| Change in working capital | 749.94 Million | -888.4 Million | 505.06 Million | -39.77 Million | 584.77 Million | -223.06 Million |
| Other non-cash items | -42.48 Million | 562.43 Million | -134.12 Million | -385.03 Million | -30.28 Million | -15.47 Million |
| Investing Cash Flow | -1.24 Billion | -1.15 Billion | -684.81 Million | -219.15 Million | -142.28 Million | -79.92 Million |
| Investments in PPE | -610.47 Million | -503.79 Million | -447.13 Million | -137.09 Million | -55.35 Million | 21.19 Million |
| Acquisitions | - | - | 142.1 Million | 90.99 Million | 22.09 Million | 20.33 Million |
| Investment purchases | -1.08 Billion | -646.3 Million | -445.5 Million | -189.4 Million | -95.44 Million | -149.87 Million |
| Sales/Maturities of investments | 454.57 Million | - | 65.48 Million | 418 Thousand | 2.03 Million | 11.85 Million |
| Other Investing Activities | -5.1 Million | -49 Thousand | 240 Thousand | 15.92 Million | -15.61 Million | 16.58 Million |
| Financing Cash Flow | -16.97 Million | 23.13 Million | 733.26 Million | -1.05 Billion | 1.72 Billion | -9.87 Million |
| Debt repayment | - | - | -401.7 Million | -2.51 Million | -401.7 Million | -21.82 Million |
| Dividends payments | - | - | -997.47 Million | -999.16 Million | - | - |
| Common Stock Repurchased | - | - | 36.25 Million | 986.95 Million | - | -1000.00 |
| Common Stock Issuance | - | - | 2.14 Billion | 14.71 Million | 2.11 Billion | -1000.00 |
| Other Financing Activities | -16.97 Million | 23.13 Million | -45.39 Million | -1.05 Billion | 3.19 Million | 33.78 Million |
| Accounts receivables | 43.22 Million | -182.77 Million | -123.03 Million | 11.45 Million | 28.98 Million | -130.24 Million |
| Accounts payables | 107.86 Million | -27.56 Million | -109.28 Million | -80.57 Million | 65.2 Million | -178.79 Million |
| Inventory | -129.94 Million | -138 Million | -116.02 Million | 176.83 Million | -76.07 Million | 62.13 Million |
| Other working capital | 728.8 Million | -540.05 Million | 853.4 Million | -147.48 Million | 566.65 Million | 23.83 Million |
| Cash at beginning of period | 8.44 Billion | 8.11 Billion | 1.94 Billion | 7.62 Billion | 3.49 Billion | 2.65 Billion |
| Cash at end of period | 9.69 Billion | 8.44 Billion | 8.11 Billion | 8.11 Billion | 7.62 Billion | 3.49 Billion |
| Capital Expenditure | -610.47 Million | -503.79 Million | -447.13 Million | -137.09 Million | -55.35 Million | 21.19 Million |
| Effect of forex changes on cash | 96.06 Million | 158.68 Million | -122.94 Million | -139.03 Million | 128.6 Million | -128.02 Million |
| Net cash flow / Change in cash | 1.24 Billion | 333.56 Million | 6.17 Billion | 492.25 Million | 4.13 Billion | 836.02 Million |
| Free Cash Flow | 1.8 Billion | 798.1 Million | 5.8 Billion | 1.77 Billion | 2.36 Billion | 1.07 Billion |
MED
ICGUF
4951
0907
AJ-R
EXS